SEC Form 4 · accession 0001019687-15-002248
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Steve Mitgang
Director
Period of report
May 15, 2015
Accepted (ET)
Jun 3, 2015 · 2:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | P | 5,000 | $0.42 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.